61. Weiss GR, Margolin KA, Aronson FR, et al. 1992. A randomized phase II trial of continuous infusion interleukin-2 or bolus injection interleukin-2 plus lymphokine-activated killer cells for advanced renal cell carcinoma. Journal of Clinical Oncology. 10:275. 62. Rosenberg SA, Yang JC, Topalian SL, et al. 1994. Treatment of 283 consecutive patients with metastatic melanoma or renal cell cancer using high-dose bolus interleukin 2. JAMA: Journal of the American Medical Association 271: 907. 63. Atkins MB, Sparano J, Fisher RI, et al. 1993. Randomized phase II trial of high-dose interleukin-2 either alone or in combination with interferon alfa-2b in advanced renal cell carcinoma. Journal of Clinical Oncology. 11:661. 64. Rubin, J.T. 1993. Interleukin-2: its biology and clinical application in patients with cancer. Cancer Invest. 11:460. 65. Smith, K.A.